PDB Short entry for 1BMK HEADER TRANSFERASE 23-JUL-98 1BMK TITLE THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (MAP KINASE P38); COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MITOGEN ACTIVATED PROTEIN KINASE; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 OTHER_DETAILS: SB218655 PYRIDINYLIMIDAZOLE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 STRAIN: BL21 (DE3); SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PET15B; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 12 OTHER_DETAILS: YES KEYWDS TRANSFERASE, INHIBITORS, MAP KINASE, SERINE/ THREONINE-PROTEIN KEYWDS 2 KINASE, P38 EXPDTA X-RAY DIFFRACTION AUTHOR Z.WANG,B.CANAGARAJAH,J.C.BOEHM,S.KASSIS,M.H.COBB,P.R.YOUNG,S.ABDEL- AUTHOR 2 MEGUID,J.L.ADAMS,E.J.GOLDSMITH REVDAT 6 03-APR-24 1BMK 1 REMARK REVDAT 5 27-DEC-23 1BMK 1 REMARK SEQADV REVDAT 4 01-FEB-17 1BMK 1 AUTHOR VERSN REVDAT 3 24-FEB-09 1BMK 1 VERSN REVDAT 2 01-APR-03 1BMK 1 JRNL REVDAT 1 23-JUL-99 1BMK 0 JRNL AUTH Z.WANG,B.J.CANAGARAJAH,J.C.BOEHM,S.KASSISA,M.H.COBB, JRNL AUTH 2 P.R.YOUNG,S.ABDEL-MEGUID,J.L.ADAMS,E.J.GOLDSMITH JRNL TITL STRUCTURAL BASIS OF INHIBITOR SELECTIVITY IN MAP KINASES. JRNL REF STRUCTURE V. 6 1117 1998 JRNL REFN ISSN 0969-2126 JRNL PMID 9753691 JRNL DOI 10.1016/S0969-2126(98)00113-0 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.RAINGEAUD,S.GUPTA,J.S.ROGERS,M.DICKENS,J.HAN,R.J.ULEVITCH, REMARK 1 AUTH 2 R.J.DAVIS REMARK 1 TITL PRO-INFLAMMATORY CYTOKINES AND ENVIRONMENTAL STRESS CAUSE REMARK 1 TITL 2 P38 MITOGEN- ACTIVATED PROTEIN KINASE ACTIVATION BY DUAL REMARK 1 TITL 3 PHOSPHORYLATION ON TYROSINE AND THREONINE REMARK 1 REF J.BIOL.CHEM. V. 270 7420 1995 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.HAN,J.D.LEE,L.BIBBS,R.J.ULEVITCH REMARK 1 TITL A MAP KINASE TARGETED BY ENDOTOXIN AND HYPEROSMOLARITY IN REMARK 1 TITL 2 MAMMALIAN CELLS REMARK 1 REF SCIENCE V. 265 808 1994 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.C.LEE,J.T.LAYDON,P.C.MCDONNELL,T.F.GALLAGHER,S.KUMAR, REMARK 1 AUTH 2 D.GREEN,D.MCNULTY,M.J.BLUMENTHAL,J.R.HEYS,S.W.LANDVATTER, REMARK 1 AUTH 3 J.E.STRICKLER,M.M.MCLAUGHLIN,I.R.SIEMENS,S.M.FISHER, REMARK 1 AUTH 4 G.P.LIVI,J.R.WHITE,J.L.ADAMS,P.R.YOUNG REMARK 1 TITL A PROTEIN KINASE INVOLVED IN THE REGULATION OF INFLAMMATORY REMARK 1 TITL 2 CYTOKINE BIOSYNTHESIS REMARK 1 REF NATURE V. 372 739 1994 REMARK 1 REFN ISSN 0028-0836 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 19034 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2833 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 94 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.330 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.78 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.674 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : PARAM19.SOL REMARK 3 PARAMETER FILE 3 : SB3_H.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH19.SOL REMARK 3 TOPOLOGY FILE 3 : SB3_H.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1BMK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JUL-99. REMARK 100 THE DEPOSITION ID IS D_1000007201. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-97 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19500 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 35.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 10.30 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.20100 REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE (CCP4), CCP4 REMARK 200 STARTING MODEL: MAP KINASE P38 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG 8000, 0.2M MG(OAC)2, 0.1M REMARK 280 HEPES, PH7.0, PH 7.4 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.79000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.75000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.61000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.75000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.79000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.61000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 GLU A 4 REMARK 475 ALA A 172 REMARK 475 ARG A 173 REMARK 475 HIS A 174 REMARK 475 THR A 175 REMARK 475 ASP A 176 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 11 132.89 175.96 REMARK 500 ASN A 14 57.75 34.77 REMARK 500 PRO A 29 141.95 -38.82 REMARK 500 VAL A 30 30.37 -141.01 REMARK 500 SER A 32 167.59 167.00 REMARK 500 SER A 56 -82.19 -58.16 REMARK 500 ASN A 100 -25.00 -151.41 REMARK 500 ASN A 115 32.14 -70.96 REMARK 500 ILE A 116 -47.32 -153.05 REMARK 500 LYS A 118 -7.59 -47.59 REMARK 500 GLN A 120 -177.91 150.00 REMARK 500 ARG A 149 -16.80 77.86 REMARK 500 LEU A 171 121.95 -22.08 REMARK 500 ALA A 172 -42.71 115.11 REMARK 500 ASP A 177 4.99 58.27 REMARK 500 LEU A 353 -145.43 -106.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SB5 A 800 DBREF 1BMK A 1 360 UNP Q16539 MK14_HUMAN 1 360 SEQADV 1BMK HIS A 48 UNP Q16539 LEU 48 CONFLICT SEQADV 1BMK ALA A 263 UNP Q16539 THR 263 CONFLICT SEQRES 1 A 379 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 A 379 VAL PRO ARG GLY SER HIS MET SER GLN GLU ARG PRO THR SEQRES 3 A 379 PHE TYR ARG GLN GLU LEU ASN LYS THR ILE TRP GLU VAL SEQRES 4 A 379 PRO GLU ARG TYR GLN ASN LEU SER PRO VAL GLY SER GLY SEQRES 5 A 379 ALA TYR GLY SER VAL CYS ALA ALA PHE ASP THR LYS THR SEQRES 6 A 379 GLY HIS ARG VAL ALA VAL LYS LYS LEU SER ARG PRO PHE SEQRES 7 A 379 GLN SER ILE ILE HIS ALA LYS ARG THR TYR ARG GLU LEU SEQRES 8 A 379 ARG LEU LEU LYS HIS MET LYS HIS GLU ASN VAL ILE GLY SEQRES 9 A 379 LEU LEU ASP VAL PHE THR PRO ALA ARG SER LEU GLU GLU SEQRES 10 A 379 PHE ASN ASP VAL TYR LEU VAL THR HIS LEU MET GLY ALA SEQRES 11 A 379 ASP LEU ASN ASN ILE VAL LYS CYS GLN LYS LEU THR ASP SEQRES 12 A 379 ASP HIS VAL GLN PHE LEU ILE TYR GLN ILE LEU ARG GLY SEQRES 13 A 379 LEU LYS TYR ILE HIS SER ALA ASP ILE ILE HIS ARG ASP SEQRES 14 A 379 LEU LYS PRO SER ASN LEU ALA VAL ASN GLU ASP CYS GLU SEQRES 15 A 379 LEU LYS ILE LEU ASP PHE GLY LEU ALA ARG HIS THR ASP SEQRES 16 A 379 ASP GLU MET THR GLY TYR VAL ALA THR ARG TRP TYR ARG SEQRES 17 A 379 ALA PRO GLU ILE MET LEU ASN TRP MET HIS TYR ASN GLN SEQRES 18 A 379 THR VAL ASP ILE TRP SER VAL GLY CYS ILE MET ALA GLU SEQRES 19 A 379 LEU LEU THR GLY ARG THR LEU PHE PRO GLY THR ASP HIS SEQRES 20 A 379 ILE ASP GLN LEU LYS LEU ILE LEU ARG LEU VAL GLY THR SEQRES 21 A 379 PRO GLY ALA GLU LEU LEU LYS LYS ILE SER SER GLU SER SEQRES 22 A 379 ALA ARG ASN TYR ILE GLN SER LEU ALA GLN MET PRO LYS SEQRES 23 A 379 MET ASN PHE ALA ASN VAL PHE ILE GLY ALA ASN PRO LEU SEQRES 24 A 379 ALA VAL ASP LEU LEU GLU LYS MET LEU VAL LEU ASP SER SEQRES 25 A 379 ASP LYS ARG ILE THR ALA ALA GLN ALA LEU ALA HIS ALA SEQRES 26 A 379 TYR PHE ALA GLN TYR HIS ASP PRO ASP ASP GLU PRO VAL SEQRES 27 A 379 ALA ASP PRO TYR ASP GLN SER PHE GLU SER ARG ASP LEU SEQRES 28 A 379 LEU ILE ASP GLU TRP LYS SER LEU THR TYR ASP GLU VAL SEQRES 29 A 379 ILE SER PHE VAL PRO PRO PRO LEU ASP GLN GLU GLU MET SEQRES 30 A 379 GLU SER HET SB5 A 800 23 HETNAM SB5 4-(FLUOROPHENYL)-1-CYCLOPROPYLMETHYL-5-(2-AMINO-4- HETNAM 2 SB5 PYRIMIDINYL)IMIDAZOLE FORMUL 2 SB5 C17 H16 F N5 FORMUL 3 HOH *94(H2 O) HELIX 1 1 ILE A 62 HIS A 77 1 16 HELIX 2 2 LEU A 113 CYS A 119 1 7 HELIX 3 3 ASP A 124 ALA A 144 1 21 HELIX 4 4 PRO A 153 ASN A 155 5 3 HELIX 5 5 ALA A 184 TYR A 188 1 5 HELIX 6 6 PRO A 191 MET A 194 1 4 HELIX 7 7 GLN A 202 THR A 218 5 17 HELIX 8 8 HIS A 228 VAL A 239 1 12 HELIX 9 9 ALA A 244 LYS A 249 1 6 HELIX 10 10 GLU A 253 SER A 261 1 9 HELIX 11 11 PHE A 270 ASN A 272 5 3 HELIX 12 12 PRO A 279 MET A 288 1 10 HELIX 13 13 SER A 293 LYS A 295 5 3 HELIX 14 14 ALA A 299 LEU A 303 1 5 HELIX 15 15 ALA A 306 PHE A 308 5 3 HELIX 16 16 PRO A 314 ASP A 316 5 3 HELIX 17 17 SER A 326 SER A 329 5 4 HELIX 18 18 ILE A 334 ILE A 346 1 13 SHEET 1 A 2 PHE A 8 LEU A 13 0 SHEET 2 A 2 THR A 16 PRO A 21 -1 N VAL A 20 O TYR A 9 SHEET 1 B 5 ASP A 88 PHE A 90 0 SHEET 2 B 5 TYR A 103 HIS A 107 -1 N VAL A 105 O ASP A 88 SHEET 3 B 5 ARG A 49 LEU A 55 -1 N LYS A 53 O LEU A 104 SHEET 4 B 5 GLY A 36 PHE A 42 -1 N ALA A 41 O VAL A 50 SHEET 5 B 5 SER A 28 GLY A 31 -1 N GLY A 31 O VAL A 38 SHEET 1 C 2 LEU A 156 VAL A 158 0 SHEET 2 C 2 LEU A 164 ILE A 166 -1 N LYS A 165 O ALA A 157 SITE 1 AC1 13 VAL A 30 GLY A 31 SER A 32 TYR A 35 SITE 2 AC1 13 VAL A 38 ALA A 51 LYS A 53 LEU A 104 SITE 3 AC1 13 VAL A 105 THR A 106 HIS A 107 LEU A 108 SITE 4 AC1 13 MET A 109 CRYST1 45.580 85.220 123.500 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021939 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011734 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008097 0.00000